Advanced Pancreatic Cancer: Flourishing Novel Approaches in the Era of Biological Therapy

The progress in the development of systemic treatment for advanced pancreatic cancer (APC) has been slow. The mainstream treatment remains using chemotherapy including gemcitabine, FOLFIRINOX, and nab-paclitaxel. Erlotinib is the only approved biological therapy with marginal benefit. Studies of age...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Chiu, Joanne W., Wong, Hilda, Leung, Roland, Pang, Roberta, Cheung, Tan-To, Fan, Sheung-Tat, Poon, Ronnie, Yau, Thomas
Médium: Artigo
Jazyk:Inglês
Vydáno: AlphaMed Press 2014
Témata:
Gastrointestinal Cancer
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4153449/
https://ncbi.nlm.nih.gov/pubmed/25117068
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2012-0131
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky